Wimol Mitrakul, MD
Family Medicine · Romeoville, ILNPI 1013066257
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 138 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,494 and has fallen 91.1% since, to $133 in 2025.
Across 138 payments — averaging $22.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$704
- Johnson & Johnson$530
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$313
- Teva Pharmaceuticals USA, Inc.$207
- Idorsia Pharmaceuticals US Inc$174
- Alkermes, Inc.$154
- plus $1K from 14 others
What the payments were for
- Food & beverage$3,095100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 34 | $704 |
| Johnson & Johnson | 17 | $530 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $313 |
| Teva Pharmaceuticals USA, Inc. | 8 | $207 |
| Idorsia Pharmaceuticals US Inc | 15 | $174 |
| Alkermes, Inc. | 7 | $154 |
| Neurocrine Biosciences, Inc. | 5 | $152 |
| Vanda Pharmaceuticals Inc. | 7 | $149 |
| Lundbeck LLC | 6 | $119 |
| Ironshore Pharmaceuticals Inc. | 5 | $88 |
| Axsome Therapeutics, Inc. | 4 | $86 |
| Almatica Pharma LLC | 3 | $77 |
| Abbott | 1 | $72 |
| AbbVie | 2 | $59 |
| Noven Therapeutics, LLC | 3 | $54 |
| Merck | 2 | $49 |
| Tris Pharma Inc | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Hikma Pharmaceuticals USA | 1 | $17 |
| Neos Therapeutics, LP | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$133
How this compares
$3,095 in reported general payments places this provider in the 85th percentile of 4,116 family medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 18 | $382 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Romeoville
- Frank PhillipsChicago$1.6M
- Peter TothSterling$1.4M
- Bradley TorphyChicago$1.3M
- Jeffrey RoyceRockford$890K
- Anthony AuriemmaWestmont$788K
- Manfred ManGurnee$764K
- Barbara BellarOakbrook Terrace$599K
- Bernie RancheroAltamont$533K
- Sandy GibsonChicago$309K
- Mandy GittlerChicago$204K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.